GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (MEX:BDX) » Definitions » YoY EBITDA Growth

Becton Dickinson (MEX:BDX) YoY EBITDA Growth : 27.72% (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Becton Dickinson YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Becton Dickinson's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 27.72%.

Becton Dickinson's EBITDA per Share for the three months ended in Dec. 2024 was MXN76.70.


Becton Dickinson YoY EBITDA Growth Historical Data

The historical data trend for Becton Dickinson's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson YoY EBITDA Growth Chart

Becton Dickinson Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.18 29.26 -0.13 -13.87 22.64

Becton Dickinson Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.57 -0.51 10.03 62.68 27.72

Becton Dickinson YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Becton Dickinson's YoY EBITDA Growth for the fiscal year that ended in Sep. 2024 is calculated as:

YoY EBITDA Growth (A: Sep. 2024 )
=(EBITDA per Share (A: Sep. 2024 )-EBITDA per Share (A: Sep. 2023 ))/ | EBITDA per Share (A: Sep. 2023 ) |
=(326.064-265.881)/ | 265.881 |
=22.64 %

Becton Dickinson's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(76.704-60.057)/ | 60.057 |
=27.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton Dickinson YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton Dickinson Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.